Novartis AG (NVS) News

Novartis AG (NVS)

Today's Latest Price: $85.69 USD

0.10 (-0.12%)

Updated Oct 20 7:00pm

Add NVS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

Filter NVS News Items

NVS News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest NVS News From Around the Web

Below are the latest news stories about Novartis Ag that investors may wish to consider to help them evaluate NVS as an investment opportunity.

Novartis announces five-year data that reinforce the safety and efficacy profile of Aimovig® (erenumab-aooe) in adult patients with episodic migraine

EAST HANOVER, N.J. , Oct. 3, 2020 /PRNewswire/ -- Novartis today announced that results reinforcing the long-term safety and efficacy profile of Aimovig ® (erenumab-aooe) in patients with episodic migraine (EM) are being presented at the Migraine Trust Virtual Symposium. Results from the five-year, open-label treatment period of a Phase 2 study in episodic migraine prevention (NCT01952574) showed Aimovig helped patients achieve sustained reductions in monthly migraine days (MMD) and in use of acute migraine-specific medication (AMSM), such as triptans. Additionally, the safety profile was consistent with what was observed in the double-blind treatment phase of the study, with no increases in adverse event rates over five years of exposure. 1 "These important data highlight the sustained...

Benzinga | October 3, 2020

IPAB quashes revocation of Novartis patent for anti-cancer drug Ceritinib

Natco filed a post-grant opposition against the patent on September 26, 2017, on grounds of obviousness and lack of inventive step.

The Financial Express | October 2, 2020

Global Gene Delivery Systems Market Research Report 2020 Featuring Amgen, Bayer, Human Stem Cells Institute, J&J, Novartis, Oxford, Biomedica, Pfizer, Shanghai Sunway Biotech, Sibiono GeneTech - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Gene Delivery Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene Delivery Systems Market to Reach $4 Billion by 2027 Amid the COVID-19 crisis, the global market for Gene Delivery Systems estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4 Billion by 2027, growing at a CAGR of 6.4% over the period 2020-2027. Viral Gene Delivery, one of the segments analyze

Business Wire | October 2, 2020

Global Pneumonia Therapeutics Market Trajectory & Analytics Report 2020 Featuring Abbott Labs, Allergan, Bayer, GlaxoSmithKline, Lupin Pharma, Merck & Co, Novartis & Pfizer - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Pneumonia Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Pneumonia Therapeutics Market to Reach US$22.5 Billion by the Year 2027 Amid the COVID-19 crisis, the global market for Pneumonia Therapeutics estimated at US$14.5 Billion in the year 2020, is projected to reach a revised size of US$22.5 Billion by 2027, growing at a CAGR of 6.5% over the analysis period 2020-2027. Drugs, one of the

Business Wire | October 2, 2020

Myxoid Round Cell Liposarcoma Drug Market 2020 Emerging Players - Adaptimmune, Recordati SpA, Merck & Co., Inc, Novartis AG, Infinity Pharmaceuticals, Inc., Mirati Therapeutics, Inc

Myxoid Round Cell Liposarcoma Drug Market Research Report By Therapy (Chemotherapy, Radiation Therapy and Others), Drugs (Trabectedin, Mechlorethamine and Others), Route of Administration (Injectable, Oral), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retailers and Others),

OpenPR | October 1, 2020

Psoriasis Drugs Market Comprehensive Growth 2020-2027 with Top key vendor Amgen, AbbVie, Novartis AG, etc

The market report study titled ‘Global Psoriasis Drugs Market Report’ published by Reports and Data offers in-depth and comprehensive research describing the scope of the market and market insights until 2027. The report will include details about potential opportunities, new

OpenPR | October 1, 2020

Dry Eye Syndrome Treatment Market 2020-2026 Refreshing Trends || Major Giants – ALLERGAN, Novartis AG, Bausch & Lomb Incorporated, Santen Pharmaceutical Co., Ltd., Johnson & Johnson Services, Inc., Akorn, Incorporated, Alcon Inc.

DBMR has added a new report titled Dry Eye Syndrome Treatment Market with analysis provides the insights which bring marketplace clearly into the focus and thus help organizations make better decisions. The data and the information regarding the industry are

OpenPR | October 1, 2020

Nuclear Medicine Imaging Market Worldwide Demand, Growth Potential & Opportunity Outlook 2027 | GE Healthcare, Curium, Lantheus Medical Imaging, Nordion, Novartis and more

Market Size – USD 3.36 billion in 2018, Market Growth - CAGR of 4.7%, Market Trends – Rising occurrences of cancer The global nuclear medicine imaging market is expected to reach USD 5.13 Billion by 2027, according to a new report

OpenPR | October 1, 2020

Global Reversible Airway Diseases Treatment Market 2020: Covering Competitive Scenario And Dynamics By Mylan N.V., Boehringer Ingelheim International GmbH, Regeneron, Sanofi, Genentech, Inc. (F. HoffmannLa Roche Ltd), Novartis AG

Data Bridge Market Research has provides the Qualitative and informative knowledge by adding titled “Global Reversible Airway Diseases Treatment Market, By Type (Bronchodilators, Cytotoxic Drugs, Antibiotics, Others), Treatment (Chest X Ray, CT Scan, Lung Therapies, Surgery Transplant and Medications), Diseases

OpenPR | October 1, 2020

STAT Plus: ‘Are you an American, sir?’: Lawmakers interrogate Amgen, Novartis, Mallinckrodt executives on why U.S. prices are so high

“If you love this country, if you love America, you should be willing to tell Americans that they shouldn't be paying more than the French, and the Germans, and Europeans,”…

STAT News | October 1, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5944 seconds.